SRL
NKTR icon

Scientech Research LLC’s Nektar Therapeutics NKTR Stock Holding History

Scientech Research LLC’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,032
Closed -$794K – 443
2026
Q1 		$794K Buy
+11,032
New +$628K 0.66% 24
2024
Q1 		– Sell
-2,015
Closed -$17.1K – 521
2023
Q4 		$17.1K Buy
+2,015
New +$15.3K 0.02% 299

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scientech Research LLC's NKTR Position: Q2 2026 in Review

Scientech Research LLC sold out of Nektar Therapeutics (NKTR) in Q2 2026, closing a stake of 11,032 shares — an estimated $794K sold.

Scientech Research LLC first reported a position in NKTR in Q4 2023 and held it in 2 quarters. The position peaked at $794K in Q1 2026. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Scientech Research LLC reported no remaining Nektar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 11,032 Nektar Therapeutics shares in Q2 2026, an estimated $794K.
  • Scientech Research LLC first reported a position in Nektar Therapeutics in Q4 2023 and held it in 2 quarters.
  • Scientech Research LLC's Nektar Therapeutics position peaked at $794K in Q1 2026.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.